Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Shelly
Shelly graduated from UPenn with a BSE in Bioengineering and a minor in Chemistry (summa cum laude). Currently, she is pursuing an MD/MSCR (Master's in Clinical Research) at the Icahn School of Medicine at Mount Sinai.
Marisa
Marisa studied Music and Biology at Yale, and graduated magna cum laude. She went on to earn her Master's in Opera Performance at Mannes School of Music at The New School.